New Zealand markets open in 9 hours 2 minutes

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0300+0.0200 (+1.98%)
At close: 04:00PM EDT
1.0400 +0.01 (+0.97%)
Pre-market: 08:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 98.35M
Enterprise value 85.12M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.37
Enterprise value/revenue N/A
Enterprise value/EBITDA -6.91

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-70.57%
S&P500 52-week change 3-4.45%
52-week high 33.6100
52-week low 30.8010
50-day moving average 30.9261
200-day moving average 31.3835

Share statistics

Avg vol (3-month) 3320.37k
Avg vol (10-day) 3472.43k
Shares outstanding 595.48M
Implied shares outstanding 6N/A
Float 861.52M
% held by insiders 150.51%
% held by institutions 13.52%
Shares short (28 Jul 2022) 41.05M
Short ratio (28 Jul 2022) 44.51
Short % of float (28 Jul 2022) 41.84%
Short % of shares outstanding (28 Jul 2022) 41.10%
Shares short (prior month 29 Jun 2022) 4998.74k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Apr 2022
Most-recent quarter (mrq)29 Apr 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-88.36%
Return on equity (ttm)-160.92%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.32M
Net income avi to common (ttm)-12.36M
Diluted EPS (ttm)-0.1140
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.06M
Total cash per share (mrq)0.15
Total debt (mrq)2.08k
Total debt/equity (mrq)0.01
Current ratio (mrq)12.37
Book value per share (mrq)0.14

Cash flow statement

Operating cash flow (ttm)-6.61M
Levered free cash flow (ttm)-2.13M